Pluri Inc. Acquisitions, Net of Cash Acquired
Pluri Inc. (PLUR) reported Acquisitions, Net of Cash Acquired of $19.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2021-09-13
- Pluri Inc. payments to acquire businesses, net of cash acquired for fiscal 2021 was $19.00K, a 45.71% decline from fiscal 2020.
- Pluri Inc. payments to acquire businesses, net of cash acquired for fiscal 2020 was $35.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|
| 2021-06-30 | $19.00K 10-K · filed 2021-09-13 |
| 2020-06-30 | $35.00K 10-K · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |